Janice Chen is the co-founder and Chief Research Officer of Mammoth Biosciences, a biotechnology company harnessing a revolutionary gene-editing tool called CRISPR for rapid and affordable disease detection. Based in San Francisco, Mammoth Biosciences is developing the next-generation CRISPR platform to create tools for reading and writing the code of life. Janice received her Ph.D. from the lab of Jennifer Doudna at University of California, Berkeley. She has authored multiple publications and patents related to CRISPR mechanism and technologies, and co-invented the programmable CRISPR-based detection technology called DETECTR. Janice was selected as a 2019 Forbes 30 Under 30 in Healthcare, and recently delivered a TEDx talk on the potential for CRISPR to democratize diagnostics.